Katerina A. Politi, Ph.D.
Affiliations: | 2003 | Columbia University, New York, NY |
Area:
Genetics, Oncology, Molecular BiologyGoogle:
"Katerina Politi"Parents
Sign in to add mentorArgiris Efstratiadis | grad student | 2003 | Columbia | |
(Genetic analysis of mouse tumorigenesis.) | ||||
Harold Elliot Varmus | post-doc | 2003-2009 | Memorial Sloan-Kettering Cancer Center |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hu B, Wiesehöfer M, de Miguel FJ, et al. (2024) ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer Research |
Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2024) EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth. Cancer Discovery. OF1-OF22 |
Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2024) EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth. Cancer Discovery |
Blair LM, Juan JM, Sebastian L, et al. (2023) Oncogenic context shapes the fitness landscape of tumor suppression. Nature Communications. 14: 6422 |
Stockhammer P, Grant M, Wurtz A, et al. (2023) Co-occurring Alterations in Multiple Tumor Suppressor Genes are Associated with Worse Outcomes in Patients with EGFR-mutant Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |
de Miguel FJ, Gentile C, Feng WW, et al. (2023) Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer. Cancer Cell |
Exposito F, Redrado M, Houry M, et al. (2023) PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer Research |
Kuhlmann-Hogan A, Cordes T, Xu Z, et al. (2023) EGFR lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth. Biorxiv : the Preprint Server For Biology |
Mart Nez-Terroba E, de Miguel FJ, Li V, et al. (2023) Overexpressed Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma Microenvironment. Biorxiv : the Preprint Server For Biology |
Grant MJ, Aredo JV, Starrett JH, et al. (2023) Efficacy of osimertinib in patients with lung cancer positive for uncommon EGFR exon 19 deletion mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |